NASHVILLE, Tenn., March 9, 2020 /PRNewswire/ -- The Nashville Health Care Council today announced the launch of Health Career Connect, an online job forum designed to connect health care employers and non-clinical talent. Primarily serving Nashville-based companies,

NORTH CHICAGO, Ill., March 9, 2020 /PRNewswire/ -- AbbVie (NYSE:ABBV) today confirmed the company's activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia (lopinavir/ritonavir) to determine its efficacy in the treatment of COVID-19.The company is collaborating with se

GRAND RAPIDS, Mich., March 9, 2020 /PRNewswire/ -- In an effort to prevent the spread of illness and ease anxiety about novel coronavirus COVID-19, Spectrum Health is offering free virtual screenings for people who are concerned they may have the virus. This allows people in Michigan to seek the information they need from their homes

NEW YORK, March 9, 2020 /PRNewswire/ -- Morgan James's new release, The Well-Referred

WALTHAM, Mass., March 9, 2020 /PRNewswire/ -- PatientKeeper®, Inc. today announced the appointment of Philip Meer as Chief Executive Office

PLYMOUTH MEETING, Pa., March 9, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (

EUGENE, Ore., March 9, 2020 /PRNewswire/ -- RAVE Reviews, the innovative site that publishes entertaining rankings based on advanced data-driven analysis, has published a ranking of the "The Best Probiotics for Men," available at:

SEATTLE, March 9, 2020 /PRNewswire/ -- Northwest Kidney Centers has conferred its highest honor, the

HILLSBOROUGH, N.C., March 9, 2020 /PRNewswire/ -- Carolina Hemp Hut, North Carolina's largest single-store provider of hemp and cannabinoid products, is pleased to announce it has been named "New Member Business of the Year" by the Hillsborough/Orange County NC Chamber of Commerce.On Friday, February 21, Carolina Hem

NEW YORK, March 9, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Thomas C. Wessel, M.D., Ph.D., has been appointed the Company's Executive Vice President and Head of Research and Development.